Neoplasia

Article	Citations
Epitranscriptomic mechanisms of androgen signalling and prostate cancer	1574
ARID1A loss sensitizes colorectal cancer cells to floxuridine	110
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma	91
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene	54
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]	54
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]	51
Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis	47
DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC	41
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling	41
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma	41
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway	40
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells	39
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD	39
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism	38
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy	37
Tumor-Infiltrating Immune Cells in Colorectal Cancer	36
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer	36
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	36
Role of heparanase 2 (Hpa2) in gastric cancer	33
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]	33
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine	32
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	31
Mutational signatures and their association with survival and gene expression in urological carcinomas	31
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	30
Leptomeningeal dissemination in pediatric brain tumors	29

Advanced progress of spatial metabolomics in head and neck cancer research	29
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations	28
Lactate promoted cisplatin resistance in NSCLC by modulating the m6A modification-mediated FOXO3/MAGI1-IT1/miR-664b-3p/IL-6R axis	28
Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications	27
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients	27
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities	27
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations	26
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications	25
Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors	25
Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma	24
Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 2021	23
An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors	23
Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis	23
Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus	22
PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes which favor proliferation	22
Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states	22
Evidence based on Mendelian randomization: Causal relationship between mitochondrial biological function and lung cancer and its subtypes	20
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR	20
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis	20
Aurkin-A, a TPX2-Aurora A small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma	20
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation	20
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection	19
β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis	19
Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats	18
Sustained experimental activation of FGF8/ERK in the developing chicken spinal cord models early events in ERK-mediated tumorigenesis	18
Aurora kinase B is required for growth and expansion of medulloblastoma cells in the tissue context	18
Inhibiting HnRNP L-mediated alternative splicing of EIF4G1 counteracts immune checkpoint blockade resistance in Castration-resistant prostate Cancer	18
Corrigendum to “SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway” [Neoplasia (2021) 23, 1037–1047]	18
High dose acetaminophen re-polarizes CD11b+ cells in the tumor microenvironment towards an activated macrophage phenotype	17
Amelioration of muscle wasting by gintonin in cancer cachexia	17
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)	17
HSP90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma	17
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature	17
Acral melanoma: new insights into the immune and genomic landscape	17
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment	17
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement	16
SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer	16
Pediatric neuro-oncology: Highlights of the last quarter-century	16
Circ_0089823 reinforces malignant behaviors of non-small cell lung cancer by acting as a sponge for microRNAs targeting SOX4,	16
The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression	16
Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma	15
Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape	15
IGDQ motogenic peptide gradient induces directional cell migration through integrin (αv)β3 activation in MDA-MB-231 metastatic breast cancer cells	15
MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability	15
Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia	15
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma	15
A bioluminescence reporter mouse model for visualizing and quantifying CD8+ T cells in vivo	15
Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening	15
Whole-chromosome arm acquired uniparental disomy in cancer development is a consequence of isochromosome formation	15
Carcinogenesis induced by space radiation: A systematic review	15

Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton	15
BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer	14
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor	14
Systemic inflammation in response to radiation drives the genesis of an immunosuppressed tumor microenvironment	13
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada	13
Comparative effects of combustible cigarette versus electronic cigarette exposures on KRAS mutant lung cancer promotion	13
PBI-05204, a supercritical CO2 extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death	13
Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]	13
Cell competition, cooperation, and cancer	13
High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer	13
PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome	13
Corrigendum to “NFAT1 hypermethylation promotes epithelial‐mesenchymal transition and metastasis in nasopharyngeal carcinoma by activating ITGA6 transcription” [Neoplasia 21 (2019): 311–321]	13
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5	13
Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.	12
Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models	12
Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors	12
Corrigendum to “Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL” [Neoplasia. Vol. 9, No. 5, May 2007, pp. 435–442]	12
Current state of pediatric neuro-oncology imaging, challenges and future directions	12
Genomics driven precision oncology in advanced biliary tract cancer improves survival	12
Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression	12
Combining selinexor with alisertib to target the p53 pathway in neuroblastoma	12
Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis	12
Impact of tissue penetration and albumin binding on design of T cell targeted bispecific agents	12
mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics	11
CYP1B1 promotes angiogenesis and sunitinib resistance in clear cell renal cell carcinoma via USP5-mediated HIF2α deubiquitination	11
LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44	11
Corrigendum to “DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer” [Neoplasia volume 2025 Apr 24:65:101166]	11
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study	11
FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma	11
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation	11
Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin	11
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus status	11
Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue	11
Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma	11
Phase I clinical trial of a novel procaspase-3 activator SM-1 with temozolomide in recurrent high-grade gliomas	11
Proprotein convertase subtilisin/kexin Type 9 is required for Ahnak-mediated metastasis of melanoma into lung epithelial cells	11
The renal clear cell carcinoma immune landscape	10
Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer	10
Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer	10
Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer	10
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization	10
ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma	10
Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer	10
RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells	10
Saturated fat exacerbates mitochondrial dysfunction through remodelling of ATP production and inflammation in Barrett’s oesophagus compared to monounsaturated fat, particularly in contrast to oesophag	10
Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors	10
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition	10
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases	10
AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling	10
Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma	10
The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia	9
Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse transplantation model	9
Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma	9
The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells	9
Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma	9
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer	9
Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling	9
Maestros of malignancy: Microbes as the conductors of carcinogenesis	9
Decoding androgen receptor signalling: Genomic vs. non-genomic roles in prostate cancer	9
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma	9
SCFβ-TrCP targets Ajuba for degradation in a GSK3β-dependent manner in colorectal cancer	8
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotype	8
The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletion	8
Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells	8
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells	8
RETRACTED: Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization	8
LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice	8
Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy	8
RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor	8
PRMT1 methylates METTL14 to modulate its oncogenic function	8
Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments	8
Genomic landscape and evolution of arm aneuploidy in lung adenocarcinoma	8
Modulation of mitochondrial function by extracellular acidosis in tumor cells and normal fibroblasts: Role of signaling pathways	8
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma –	8
IL-6 facilitates cross-talk between epithelial cells and tumor- associated macrophages in Helicobacter pylori-linked gastric carcinogenesis	8
Immunohistochemical and molecular evolutionary features of jejunoileal adenocarcinoma unveiled through comparative analysis with colorectal adenocarcinoma	8
circUBR5 promotes ribosome biogenesis and induces docetaxel resistance in triple-negative breast cancer cell lines via the miR-340-5p/CMTM6/c-MYC axis	8
Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer	8
Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model	8
Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function	8

MYC alterations in multiple myeloma: Genetic insights and prognostic impact	8
Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.	8
Clinical and genetic drivers of oligo-metastatic disease in colon cancer	8
Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape	7
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC	7
Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis	7
Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma	7
The promise of metabolic imaging in diffuse midline glioma	7
Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy	7
In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer	6
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation	6
Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing	6
Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40	6
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas	6
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas	6
The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms	6
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer	6
Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation	6
Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data	6
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer	6
Microbial molecules, metabolites, and malignancy	6
The breast tissue microbiome, stroma, immune cells and breast cancer	6
Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision	6
Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting	6
Kv11.1-dependent senescence activates a lethal immune response via tumor necrosis factor alpha	6
Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer	6
Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma	5
Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer	5
Depletion of β1,6-N-acetylglucosaminyltransferase reduces E-selectin binding capacity and migratory potential of human gastrointestinal adenocarcinoma cells	5
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis	5
A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomas	5
An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity	5
Engineering and characterization of Hu3A4: A novel humanized antibody with potential as a therapeutic agent against myeloid lineage leukemias	5
Exosomes in review: A new frontier in CAR-T cell therapies	5
Suppression of ER-stress induction of GRP78 as an anti-neoplastic mechanism of the cardiac glycoside Lanatoside C in pancreatic cancer	5
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system	5
Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma	5
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma	4
Tumor neoantigens as key drivers of significant anti - tumor immunity in triple - negative breast cancer mouse models	4
Insights into the metastatic bone marrow niche gained from fibronectin and β1 integrin transgenic mice	4
[18F]-FLT-PET to evaluate how the sequencing of chemotherapies impacts the efficacy of combination treatment in mouse models of triple-negative breast cancer	4
Retraction notice to Corrigendum to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 31 (2022) 100805]	4
A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity	4
Retraction notice to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 27 (2022) 100784]	4
Copy number alteration of the interferon gene cluster in cancer: Individual patient data meta-analysis prospects to personalized immunotherapy	4
Corrigendum to “Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E” [Neoplasia, volume 12,	4
MLH1 mediates cytoprotective nucleophagy to resist 5-Fluorouracil-induced cell death in colorectal carcinoma	4
Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells	4
STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma	4
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis	4
Specifying the choice of EGFR-TKI based on brain metastatic status for advanced NSCLC with EGFR p.L861Q mutation	4
Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export	4
PI3K-CCL2-CCR2-MDSCs axis: A potential pathway for tumor Clostridia-promoted CD 8+ T lymphocyte infiltration in bile tract cancers	4
Corrigendum to Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1 α/miR-494/Survivin signaling pathway [Volume 32 Number xxx Month 2022 pp. 100821]	4
SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy	4
miRTARGET: An integrated web tool for the identification of microRNA targets with potential therapeutic or prognostic value in cancer	4
Global molecular alterations involving recurrence or progression of pediatric brain tumors	4
YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma	4
Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer	4
DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway	4
Effect of MisMatch repair deficiency on metastasis occurrence in a syngeneic mouse model	3
Transcriptomic and proteomic profiling identifies feline fibrosarcoma as clinically amenable model for aggressive sarcoma subtypes	3
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy	3
True cancer stem cells exhibit relative degrees of dormancy and genomic stability	3
FABP4 facilitates epithelial-mesenchymal transition via elevating CD36 expression in glioma cells	3
Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis	3
GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors	3
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures	3
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer	3
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance	3
Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways	3
Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis	3
Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients	3
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy	3
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis	3
Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection	3
Proteome biology of primary colorectal carcinoma and corresponding liver metastases	3
Corrigendum to “Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.” [Neoplasia Volume 23, Iss	3
Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells	3
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma	3
Targeting IL-23 for the interception of obesity-associated colorectal cancer	3
Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers	3
Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-XL dual inhibitor that induces Bax-dependent apoptosis	3
Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats	3
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center	3
Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling	3
Characterization and integrated analysis of extrachromosomal DNA amplification in hematological malignancies	3
Efficacy and safety of pyrotinib-based regimens in HER2 positive metastatic breast cancer: A retrospective real-world data study	3
Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10	3
Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells	3
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis	3
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era	3
RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer	3
Interdisciplinary care of children with diffuse midline glioma	3